RO5186582

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RO5186582, covering 2016-11-02 to 2017-07-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age [Phase 2]